CRON | Thinking about buying stock in O2Micro International, Sasol Limited, 3D Systems, Cronos Group, or Sorrento Therapeutics? – Stocks News Feed

Share this Stock InformationNEW YORK, Nov.3, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for OIIM, SSL, DDD, CRON, and SRNE.To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link.(Note: You may have to copy this link into your browser then press the… Read More […]

CRON | CBD Oil Extract Market Outlook, Growth Analysis, Business Opportunities and Forecasts 2019 – 2026 | With Key Players Analysis On Tikun Olam, The Cronos Group, Kazmira, FOLIUM BIOSCIENCES, HempLife Today, CBD American Shaman., PharmaHemp

DBMR has added a new report titled CBD Oil Extract Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis.A market research analysis and estimations carriedOpenPR

CRON | Cronos Group (CRON) & The Competition Critical Contrast

Cronos Group (NASDAQ: CRON) is one of 36 public companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare Cronos Group to related businesses based on the strength of its valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.Insider and Institutional Ownership 12.1% of Cronos […]Stock […]

CRON | Head-To-Head Analysis: Cronos Group (CRON) vs. Its Competitors

Cronos Group (NASDAQ: CRON) is one of 36 public companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare Cronos Group to related companies based on the strength of its dividends, earnings, risk, institutional ownership, profitability, valuation and analyst recommendations.Earnings and Valuation This table compares Cronos […]Stock […]

CRON | Comparing Cronos Group (CRON) and Its Competitors

Cronos Group (NASDAQ: CRON) is one of 36 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its rivals? We will compare Cronos Group to similar companies based on the strength of its valuation, analyst recommendations, profitability, risk, institutional ownership, dividends and earnings.Profitability This table compares Cronos Group and […]Dispatch […]